2021
DOI: 10.1016/j.jss.2020.11.042
|View full text |Cite
|
Sign up to set email alerts
|

The Effects of Volatile Anesthetics on Lung Ischemia-Reperfusion Injury: Basic to Clinical Studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 136 publications
0
6
0
Order By: Relevance
“…Sevoflurane is a volatile anesthetic that is frequently used in the clinic due to its advantages, such as having a low blood-gas partition coefficient, providing sufficient depth of anesthesia in a short time, short awakening time, less airway irritation, and being able to be used in inhalation anesthesia. 35 The protective effects of sevoflurane at different pathways in IRI have been demonstrated in various studies.…”
Section: Discussionmentioning
confidence: 99%
“…Sevoflurane is a volatile anesthetic that is frequently used in the clinic due to its advantages, such as having a low blood-gas partition coefficient, providing sufficient depth of anesthesia in a short time, short awakening time, less airway irritation, and being able to be used in inhalation anesthesia. 35 The protective effects of sevoflurane at different pathways in IRI have been demonstrated in various studies.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, longer isoflurane-maintained anesthesia induced more alveolar macrophage aggregation, but less phagocytic activity (Kotani et al 1998). Long term exposure to isoflurane is also related to airway inflammation (Oshima et al;Odeh et al 2022. IL-8 is one of the key chemokines involved in the migration of epithelial granulocytes, which promote pulmonary inflammation and asthma (Cromwell et al 1992).…”
Section: Discussionmentioning
confidence: 99%
“…A potential role of the anaesthetic regimen on the rate of postoperative pulmonary complications (PPCs) in cardiac surgery has been suggested [ 2 ]. Proposed mechanisms for VA lung protection include anti-inflammatory, antioxidant, and anti-apoptotic effects on endothelial cells, immunocompetent cells, and epithelial cells by inhibiting nuclear factor kappa B (NF-kB), mitogen-activated protein kinase (MAPK), and protein kinase C (PKC) signalling, as well as by inhibiting overexpression of inducible nitric oxide synthase (iNOS) and maintaining expression of endothelial nitric oxide synthase (eNOS) [ 99 ]. These lung protective effects of VA might be triggered by the small amounts of ROS induced by VA. VA also exert a lung protective effect on the glycocalyx present on the surface of pulmonary endothelium and on the tight junctions between alveolar epithelial and endothelial cells [ 99 ].…”
Section: Clinical Translation Of Anaesthetic Cardioprotectionmentioning
confidence: 99%